Endocrine Testing Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Endocrine Testing Market covers analysis By Test (Thyroid, Insulin, Follicle Stimulating Hormone, Estradiol, Testosterone, Luteinizing Hormone, Progesterone, DHEA-S, Prolactin, Human Chorionic Gonadotropin, Cortisol and Others); Technology (Immunoassay, Tandem Mass Spectrometry, Monoclonal and Polyclonal Antibody, Sensor Technology, Clinical Chemistry and others); End User (Hospitals, Diagnostic Laboratory and Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Publication Month : Apr 2024

  • Report Code : TIPRE00004158
  • Category : Biotechnology
  • Status : Upcoming
  • No. of Pages : 150
Inquire Before Buy

PRICING

$5190

$4671

MARKET INTRODUCTION
Endocrine Testing is performed to measure the endocrine hormone concentration for diagnosing various disorders such as diabetes, hypothyroidism, infertility and other hormonal disorder.

MARKET DYNAMICS
The Endocrine Testing market is anticipated to grow in the forecast, owing to the factors such as rising prevalence of endocrinal disorders such as diabetes, infertility etc., launch of new products, growing prevalence of lifestyle disease, growing population of obese patients, rising geriatric population and increasing government support. Nevertheless, unaffordability of the Endocrine Testing Equipment and lack of awareness in certain regions is expected to hamper the market growth during the forecast period.

MARKET SCOPE
The "Global Endocrine Testing Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Endocrine Testing market with detailed market segmentation by Test, Technology, End User and geography. The global Endocrine Testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Endocrine Testing Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Endocrine Testing market is segmented on the basis of Test, Technology and End User. Based on Test the market is segmented into Thyroid, Insulin, Follicle Stimulating Hormone, Estradiol, Testosterone, Luteinizing Hormone, Progesterone, DHEA-S, Prolactin, Human Chorionic Gonadotropin, Cortisol and Others. Based on Technology the market is segmented into Immunoassay, Tandem Mass Spectrometry, Monoclonal and Polyclonal Antibody, Sensor Technology, Clinical Chemistry and others. Based on End User the market is segmented into Hospitals, Diagnostic Laboratory and Others. REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Endocrine Testing market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Endocrine Testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Endocrine Testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Endocrine Testing market in these regions.

World Geography

Have a question?

Analyst

Akshay

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Endocrine Testing market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Endocrine Testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Endocrine Testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Endocrine Testing market in these regions.

MARKET PLAYERS
The reports cover key developments in the Endocrine Testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Endocrine Testing market are anticipated to lucrative growth opportunities in the future with the rising demand for Endocrine Testing market in the global market. Below mentioned is the list of few companies engaged in the Endocrine Testing market.

The report also includes the profiles of Endocrine Testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Abbott Laboratories
  • AB Sciex Pte. Ltd
  • Agilent Technologies
  • Biomedical Technologies
  • DiaSorin S.p.A
  • F.Hoffmann-La Roche Ltd
  • LabCorp
  • Ortho Clinical Technologies
  • Quest Technology
  • Siemens Healthcare
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Endocrine Testing Market - By Test
1.3.2 Endocrine Testing Market - By Technology
1.3.3 Endocrine Testing Market - By End User
1.3.4 Endocrine Testing Market - By Technology
1.3.5 Endocrine Testing Market - By Region
1.3.5.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ENDOCRINE TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ENDOCRINE TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ENDOCRINE TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. ENDOCRINE TESTING - GLOBAL MARKET OVERVIEW
6.2. ENDOCRINE TESTING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ENDOCRINE TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TEST
7.1. OVERVIEW
7.2. TEST MARKET FORECASTS AND ANALYSIS
7.3. THYROID
7.3.1. Overview
7.3.2. Thyroid Market Forecast and Analysis
7.4. INSULIN
7.4.1. Overview
7.4.2. Insulin Market Forecast and Analysis
7.5. FOLLICLE STIMULATING HORMONE
7.5.1. Overview
7.5.2. Follicle Stimulating Hormone Market Forecast and Analysis
7.6. ESTRADIOL
7.6.1. Overview
7.6.2. Estradiol Market Forecast and Analysis
7.7. TESTOSTERONE
7.7.1. Overview
7.7.2. Testosterone Market Forecast and Analysis
7.8. LUTEINIZING HORMONE
7.8.1. Overview
7.8.2. Luteinizing Hormone Market Forecast and Analysis
7.9. PROGESTERONE
7.9.1. Overview
7.9.2. Progesterone Market Forecast and Analysis
7.10. DHEA-S
7.10.1. Overview
7.10.2. DHEA-S Market Forecast and Analysis
7.11. PROLACTIN
7.11.1. Overview
7.11.2. Prolactin Market Forecast and Analysis
7.12. HUMAN CHORIONIC GONADOTROPIN
7.12.1. Overview
7.12.2. Human Chorionic Gonadotropin Market Forecast and Analysis
7.13. CORTISOL AND OTHERS
7.13.1. Overview
7.13.2. Cortisol and Others Market Forecast and Analysis
8. ENDOCRINE TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. IMMUNOASSAY
8.3.1. Overview
8.3.2. Immunoassay Market Forecast and Analysis
8.4. TANDEM MASS SPECTROMETRY
8.4.1. Overview
8.4.2. Tandem Mass Spectrometry Market Forecast and Analysis
8.5. MONOCLONAL AND POLYCLONAL ANTIBODY
8.5.1. Overview
8.5.2. Monoclonal and Polyclonal Antibody Market Forecast and Analysis
8.6. SENSOR TECHNOLOGY
8.6.1. Overview
8.6.2. Sensor Technology Market Forecast and Analysis
8.7. CLINICAL CHEMISTRY AND OTHERS
8.7.1. Overview
8.7.2. Clinical Chemistry and others Market Forecast and Analysis
9. ENDOCRINE TESTING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. DIAGNOSTIC LABORATORY AND OTHERS
9.4.1. Overview
9.4.2. Diagnostic Laboratory and Others Market Forecast and Analysis
10. ENDOCRINE TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
10.1. OVERVIEW
10.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
10.3. IMMUNOASSAY
10.3.1. Overview
10.3.2. Immunoassay Market Forecast and Analysis
10.4. TANDEM MASS SPECTROMETRY
10.4.1. Overview
10.4.2. Tandem Mass Spectrometry Market Forecast and Analysis
10.5. MONOCLONAL AND POLYCLONAL ANTIBODY
10.5.1. Overview
10.5.2. Monoclonal and Polyclonal Antibody Market Forecast and Analysis
10.6. SENSOR TECHNOLOGY
10.6.1. Overview
10.6.2. Sensor Technology Market Forecast and Analysis
10.7. CLINICAL CHEMISTRY AND OTHERS
10.7.1. Overview
10.7.2. Clinical Chemistry and others Market Forecast and Analysis
11. ENDOCRINE TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Endocrine Testing Market Overview
11.1.2 North America Endocrine Testing Market Forecasts and Analysis
11.1.3 North America Endocrine Testing Market Forecasts and Analysis - By Test
11.1.4 North America Endocrine Testing Market Forecasts and Analysis - By Technology
11.1.5 North America Endocrine Testing Market Forecasts and Analysis - By End User
11.1.6 North America Endocrine Testing Market Forecasts and Analysis - By Technology
11.1.7 North America Endocrine Testing Market Forecasts and Analysis - By Countries
11.1.7.1 United States Endocrine Testing Market
11.1.7.1.1 United States Endocrine Testing Market by Test
11.1.7.1.2 United States Endocrine Testing Market by Technology
11.1.7.1.3 United States Endocrine Testing Market by End User
11.1.7.1.4 United States Endocrine Testing Market by Technology
11.1.7.2 Canada Endocrine Testing Market
11.1.7.2.1 Canada Endocrine Testing Market by Test
11.1.7.2.2 Canada Endocrine Testing Market by Technology
11.1.7.2.3 Canada Endocrine Testing Market by End User
11.1.7.2.4 Canada Endocrine Testing Market by Technology
11.1.7.3 Mexico Endocrine Testing Market
11.1.7.3.1 Mexico Endocrine Testing Market by Test
11.1.7.3.2 Mexico Endocrine Testing Market by Technology
11.1.7.3.3 Mexico Endocrine Testing Market by End User
11.1.7.3.4 Mexico Endocrine Testing Market by Technology
11.1.7.4 US Endocrine Testing Market
11.1.7.4.1 US Endocrine Testing Market by Test
11.1.7.4.2 US Endocrine Testing Market by Technology
11.1.7.4.3 US Endocrine Testing Market by End User
11.1.7.4.4 US Endocrine Testing Market by Technology
11.2. EUROPE
11.2.1 Europe Endocrine Testing Market Overview
11.2.2 Europe Endocrine Testing Market Forecasts and Analysis
11.2.3 Europe Endocrine Testing Market Forecasts and Analysis - By Test
11.2.4 Europe Endocrine Testing Market Forecasts and Analysis - By Technology
11.2.5 Europe Endocrine Testing Market Forecasts and Analysis - By End User
11.2.6 Europe Endocrine Testing Market Forecasts and Analysis - By Technology
11.2.7 Europe Endocrine Testing Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Endocrine Testing Market
11.2.7.1.1 Germany Endocrine Testing Market by Test
11.2.7.1.2 Germany Endocrine Testing Market by Technology
11.2.7.1.3 Germany Endocrine Testing Market by End User
11.2.7.1.4 Germany Endocrine Testing Market by Technology
11.2.7.2 France Endocrine Testing Market
11.2.7.2.1 France Endocrine Testing Market by Test
11.2.7.2.2 France Endocrine Testing Market by Technology
11.2.7.2.3 France Endocrine Testing Market by End User
11.2.7.2.4 France Endocrine Testing Market by Technology
11.2.7.3 Italy Endocrine Testing Market
11.2.7.3.1 Italy Endocrine Testing Market by Test
11.2.7.3.2 Italy Endocrine Testing Market by Technology
11.2.7.3.3 Italy Endocrine Testing Market by End User
11.2.7.3.4 Italy Endocrine Testing Market by Technology
11.2.7.4 Spain Endocrine Testing Market
11.2.7.4.1 Spain Endocrine Testing Market by Test
11.2.7.4.2 Spain Endocrine Testing Market by Technology
11.2.7.4.3 Spain Endocrine Testing Market by End User
11.2.7.4.4 Spain Endocrine Testing Market by Technology
11.2.7.5 United Kingdom Endocrine Testing Market
11.2.7.5.1 United Kingdom Endocrine Testing Market by Test
11.2.7.5.2 United Kingdom Endocrine Testing Market by Technology
11.2.7.5.3 United Kingdom Endocrine Testing Market by End User
11.2.7.5.4 United Kingdom Endocrine Testing Market by Technology
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Endocrine Testing Market Overview
11.3.2 Asia-Pacific Endocrine Testing Market Forecasts and Analysis
11.3.3 Asia-Pacific Endocrine Testing Market Forecasts and Analysis - By Test
11.3.4 Asia-Pacific Endocrine Testing Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific Endocrine Testing Market Forecasts and Analysis - By End User
11.3.6 Asia-Pacific Endocrine Testing Market Forecasts and Analysis - By Technology
11.3.7 Asia-Pacific Endocrine Testing Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Endocrine Testing Market
11.3.7.1.1 Australia Endocrine Testing Market by Test
11.3.7.1.2 Australia Endocrine Testing Market by Technology
11.3.7.1.3 Australia Endocrine Testing Market by End User
11.3.7.1.4 Australia Endocrine Testing Market by Technology
11.3.7.2 China Endocrine Testing Market
11.3.7.2.1 China Endocrine Testing Market by Test
11.3.7.2.2 China Endocrine Testing Market by Technology
11.3.7.2.3 China Endocrine Testing Market by End User
11.3.7.2.4 China Endocrine Testing Market by Technology
11.3.7.3 India Endocrine Testing Market
11.3.7.3.1 India Endocrine Testing Market by Test
11.3.7.3.2 India Endocrine Testing Market by Technology
11.3.7.3.3 India Endocrine Testing Market by End User
11.3.7.3.4 India Endocrine Testing Market by Technology
11.3.7.4 Japan Endocrine Testing Market
11.3.7.4.1 Japan Endocrine Testing Market by Test
11.3.7.4.2 Japan Endocrine Testing Market by Technology
11.3.7.4.3 Japan Endocrine Testing Market by End User
11.3.7.4.4 Japan Endocrine Testing Market by Technology
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Endocrine Testing Market Overview
11.4.2 Middle East and Africa Endocrine Testing Market Forecasts and Analysis
11.4.3 Middle East and Africa Endocrine Testing Market Forecasts and Analysis - By Test
11.4.4 Middle East and Africa Endocrine Testing Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa Endocrine Testing Market Forecasts and Analysis - By End User
11.4.6 Middle East and Africa Endocrine Testing Market Forecasts and Analysis - By Technology
11.4.7 Middle East and Africa Endocrine Testing Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Endocrine Testing Market
11.4.7.1.1 South Africa Endocrine Testing Market by Test
11.4.7.1.2 South Africa Endocrine Testing Market by Technology
11.4.7.1.3 South Africa Endocrine Testing Market by End User
11.4.7.1.4 South Africa Endocrine Testing Market by Technology
11.4.7.2 Saudi Arabia Endocrine Testing Market
11.4.7.2.1 Saudi Arabia Endocrine Testing Market by Test
11.4.7.2.2 Saudi Arabia Endocrine Testing Market by Technology
11.4.7.2.3 Saudi Arabia Endocrine Testing Market by End User
11.4.7.2.4 Saudi Arabia Endocrine Testing Market by Technology
11.4.7.3 U.A.E Endocrine Testing Market
11.4.7.3.1 U.A.E Endocrine Testing Market by Test
11.4.7.3.2 U.A.E Endocrine Testing Market by Technology
11.4.7.3.3 U.A.E Endocrine Testing Market by End User
11.4.7.3.4 U.A.E Endocrine Testing Market by Technology
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Endocrine Testing Market Overview
11.5.2 South and Central America Endocrine Testing Market Forecasts and Analysis
11.5.3 South and Central America Endocrine Testing Market Forecasts and Analysis - By Test
11.5.4 South and Central America Endocrine Testing Market Forecasts and Analysis - By Technology
11.5.5 South and Central America Endocrine Testing Market Forecasts and Analysis - By End User
11.5.6 South and Central America Endocrine Testing Market Forecasts and Analysis - By Technology
11.5.7 South and Central America Endocrine Testing Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Endocrine Testing Market
11.5.7.1.1 Brazil Endocrine Testing Market by Test
11.5.7.1.2 Brazil Endocrine Testing Market by Technology
11.5.7.1.3 Brazil Endocrine Testing Market by End User
11.5.7.1.4 Brazil Endocrine Testing Market by Technology
11.5.7.2 Argentina Endocrine Testing Market
11.5.7.2.1 Argentina Endocrine Testing Market by Test
11.5.7.2.2 Argentina Endocrine Testing Market by Technology
11.5.7.2.3 Argentina Endocrine Testing Market by End User
11.5.7.2.4 Argentina Endocrine Testing Market by Technology
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ENDOCRINE TESTING MARKET, KEY COMPANY PROFILES
13.1. ABBOTT LABORATORIES
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AB SCIEX PTE. LTD
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. AGILENT TECHNOLOGIES
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BIOMEDICAL TECHNOLOGIES
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. DIASORIN S.P.A
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. F.HOFFMANN-LA ROCHE LTD
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. LABCORP
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ORTHO CLINICAL TECHNOLOGIES
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. QUEST TECHNOLOGY
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SIEMENS HEALTHCARE
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TER
The List of Companies

- Abbott Laboratories
- AB Sciex Pte. Ltd
- Agilent Technologies
- Biomedical Technologies
- DiaSorin S.p.A
- F.Hoffmann-La Roche Ltd
- LabCorp
- Ortho Clinical Technologies
- Quest Technology
- Siemens Healthcare

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Endocrine Testing Market